A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Remdesivir-13C6
| Chemical Name | : | Remdesivir-13C6 |
|---|---|---|
| Catalog Number | : | CS-O-35826 |
| CAS Number | : | 1809249-37-3 (Unlabeled) |
| Status | : |
|
| Category | : | Remdesivir Stable Isotopes |
| Molecular Weight | : | 608.53 mol/g |
| Molecular Formula | : | C2113C6H35N6O8P |
| List Price | Online Price | Size | Stock Status | Quantity | |
|---|---|---|---|---|---|
|
|||||
Need custom pricing for Remdesivir-13C6?
Please enter the following information to view price.
Shipping & Availability
| Status | : |
Remdesivir-13C6 -
|
|---|---|---|
| Do you deliver in USA? | : | We offer free shipping of Remdesivir-13C6 in USA , Canada and major countries worldwide. |
| COA | : | View COA |
| MSDS | : | View Sample MSDS |
More Information
| Payment mode | : | Credit / Debit / Purchase Order |
|---|---|---|
| Taxes | : | All prices are inclusive taxes |
| Refund Policy | : | 30 days money back guarantee |
| Canonical SMILES | : | CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4 |
| Isomeric SMILES | : | CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@@H]1[C@H]([C@H]([C@](O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4 |
| InChI | : | InChI=1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1 |
| InchIKey | : | RWWYLEGWBNMMLJ-YSOARWBDSA-N |
| IUPAC Name | : | 2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate |
| Exact Mass | : | 602.22539909 |
| Use Classification | : | Human drugs -> Veklury -> EMA Drug Category |
| Hazard Class | : | STOT RE 1 (66.67%) |
| Description | : | Remdesivir is a carboxylic ester resulting from the formal condensation of the carboxy group of N-[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]-L-alanine with the hydroxy group of 2-ethylbutan-1-ol. A broad-spectrum antiviral prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus, MERS-CoV and SARS-CoV. It is currently in Phase III clinical trials for the treatment of Covid-19 in adults. It has a role as an antiviral drug, a prodrug and an anticoronaviral agent. It is a carboxylic ester, a pyrrolotriazine, a nitrile, a phosphoramidate ester, a C-nucleoside and an aromatic amine. It derives from a GS-441524. |
| EC Number | : | 852-825-8 |
| Toxicity Summary | : | Data regarding overdoses of remdesivir are not readily available. Overdoses of other nucleoside analogs like acyclovir can be managed with symptomatic and supportive treatment. |
